Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Sanyou Biopharmaceuticals Expands Global Reach with New Cambridge Office
January 11, 2025
Company
Drug
Sanofi’s Dupixent Receives Priority Review for Prurigo Nodosa Treatment
January 11, 2025
Policy / Regulatory
China’s Premier Li Keqiang Highlights Economic and Social Advances in Annual Report
January 11, 2025
Company
Drug
Eli Lilly’s Retevmo Launched in China by Innovent Biologics
January 11, 2025
Company
Deals
QL Biopharm Raises Series B Funding for Protein Drug Development
January 11, 2025
Company
Drug
Huahai Pharma’s HB0025 Receives NMPA Approval for Clinical Trials
January 11, 2025
Company
Drug
Hengrui’s Adebrelimab Receives NMPA Approval for Lung Cancer Treatment
January 11, 2025
Company
Deals
Siyi Intelligence Raises Series A Funding for Neural Rehabilitation Solutions
January 11, 2025
Company
Drug
Sino Biopharmaceutical’s Bevacizumab Biosimilar Approved by NMPA
January 11, 2025
Company
Drug
Mabwell’s 9MW3911 Monoclonal Antibody Accepted for NMPA Review
January 11, 2025
Company
Drug
Venus Medtech Completes Patient Enrollment for Liwen RF Ablation System Study
January 11, 2025
Company
Deals
PulseCare Raises Pre-Series A Funding for Minimally Invasive Treatment Devices
January 11, 2025
1
2
…
1,018
1,019
1,020
1,021
1,022
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?